EZH2 and breast carcinoma: More to the point, ANCR is necessary for the binding of CDK1 to EZH2, where CDK1 marks EZH2 for ubiquitin-proteasome degradation via Thr-345 and Thr-487 phosphorylation in breast cancer cells.